CCRM
Aisha Mohamed is currently working as a Development Associate at CCRM since April 2022. Prior to this, Aisha held positions such as Program Manager and Program Facilitator at Visions of Science, Standards and Terminology Analyst at eHealth Ontario, and Research Technician at Insception Lifebank Cord Blood Program. Aisha also has experience as a Summer Research Student at The Hospital for Sick Children, Senior Program Facilitator at Boys and Girls Clubs of Canada, and Research Translation Assistant at York University. Aisha holds a Master of Science in Regenerative Medicine/Developmental Biology from the University of Toronto and a Bachelor of Science in Biomedical Sciences from York University.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.